Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Geron Q2 EPS $(0.02) Beats $(0.03) Estimate, Sales $49.036M Beat $47.281M Estimate

Author: Benzinga Newsdesk | August 06, 2025 07:03am
Geron (NASDAQ:GERN) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 80 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $49.036 million which beat the analyst consensus estimate of $47.281 million by 3.71 percent. This is a 5.46K percent increase over sales of $882.000 thousand the same period last year.

Posted In: GERN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist